Aortic stenosis is a condition in which the opening of the aortic valve narrows, restricting blood flow from the heart to the rest of the body. The American Heart Association estimates that over 20% of older Americans have aortic stenosis, referring to it as a condition “common in people over age 65.”¹ Despite its prevalence,…
The presence of AF after TAVR may be associated with changes in left ventricular mass index.
Transcatheter aortic valve replacement in failed TAVs was found to be associated with greater procedural success than TAV in failed surgical aortic valve.
In 2019, TAVR exceeded surgical procedures; 30-day mortality and stroke rates decreased since 2011.
The Emory risk score was found to have modest value for predicting permanent pacemaker implantation.
Coronary cannulation failures following transcatheter aortic valve replacement were found to be higher in patients receiving Evolut TAVs.
Outcomes of transfemoral TAVR for symptomatic severe aortic stenosis were comparable with the self-expanding transcatheter ACURATE neo valve or the CoreValve Evolut valve.
Tricuspid annular dilation may be an independent predictor of all-cause mortality after transcatheter aortic valve replacement for severe aortic stenosis.
The second-generation SAPIEN XT balloon-expandable valve was found to have a higher 5-year rate of structural valve deterioration compared with surgical aortic valve replacement.
A novel pigtail/J-wire technique for crossing stenotic aortic valves was found to be rapid, simple, and safe to implement.
